EUVIMED · CrossrefJournal
Cancer Diagnosis & Prognosis
ISSN 2732-7787 · International Institute of Anticancer Research
Latest articles
Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer
Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: A Single-institution Retrospective Study
Baseline Peripheral Neuropathy Predicts Clinically Significant Neuropathy During Paclitaxel Treatment Following Oxaliplatin-based Chemotherapy
Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer
Association Between S-1 Treatment Duration and Disease Control in Advanced Non-small-cell Lung Cancer
Prognostic Relevance of Surface α-Enolase (ENO1) in Patients With Lung Adenocarcinoma
From Biopsy to Pathology: A Retrospective Cohort Study of Predictors of Gleason Score Upgrading in Grade Group 1 Prostate Cancer
Intramuscular Myxoma of the Shoulder in Neurofibromatosis Type 1
Granular Cell Tumor of the Gallbladder: A Rare Entity
Primary Male Appendiceal Choriocarcinoma With Background of Low-Grade Appendiceal Mucinous Neoplasm: Diagnostic Challenges and Poor Prognosis
Merkel Cell Polyomavirus-Negative Merkel Cell Carcinoma Presenting in the Parotid Gland: Precise Diagnosis and Complete Pathological Response to Nivolumab
Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer
Impact of Local Treatment of the Primary Tumor on Overall Survival in De Novo Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Lipid Profiles in Breast Cancer: Clinical Associations and Biological Insights
CDKN2A mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric Adenocarcinoma
Optimized Prostate Cancer Stage Classification Using XGBoost Based on Racial miRNA Expression
Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period
Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment
Prognostic Impact of Skeletal Muscle Radiodensity in Advanced Urothelial Carcinoma Undergoing Avelumab Maintenance Therapy
Prognosis Using Modified Albumin–Bilirubin Grade in Resected Biliary Tract Cancer: A Multicenter Propensity Score–matched Analysis
Comparison of Automated Urinalysis Parameter Atyp.C and Urine Cytology for Detecting Bladder Carcinoma In Situ
Tumor Marker Index Based on CEA and CA19-9 as a Prognostic Biomarker in Resectable Colon Cancer
The Clinical Impact of Prognostic Nutritional Index at Recurrence of Pancreatic Cancer
The Impact of Comprehensive Panel NGS Testing and Cascade Family Screening on Early Diagnosis of Prostate Cancer and MINAS (ATM+MITF) Management
Possible Sarcopenia and Functional Decline After Colorectal or Gastric Cancer Surgery
Total Bone Uptake as a Quantitative Imaging Biomarker for Prostate Cancer With Bone Metastases
Clinical Significance of Transjugular Liver Biopsy in Liver Dysfunction During Immune Checkpoint Inhibitor Therapy
Early Initiation of Adjuvant Nivolumab After Esophagectomy Is Associated With Immune-related Liver Injury
Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion
From Ascites to Malignant Peritoneal Mesothelioma: The Diagnostic Workup of a Rare Tumor
EUVIMED